| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $59.8M | +115.1% |
| Cost of Revenue | $35.6M | +29.7% |
| Gross Profit | $24.2M | +6587.8% |
| R&D Expense | $15.7M | +1.0% |
| SG&A Expense | $114.9M | +64.3% |
| Operating Income | -$106.4M | -25.1% |
| Pre-tax Income | -$113.7M | -20.8% |
| Income Tax | $135K | +462.5% |
| Net Income | -$113.8M |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $237.6M | +2780.3% |
| Accounts Receivable | $8.1M | +304.5% |
| Current Assets | $255.3M | +1612.8% |
| Total Assets | $295.7M | +543.6% |
| Current Liabilities | $38.0M | +15.2% |
| Long-term Debt | $41.1M | -3.4% |
| Total Liabilities | $90.3M | +15.5% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.6M | -7.4% |
| Capital Expenditures | $22.9M | +87.6% |
| Investing Cash Flow | -$23.3M | -90.6% |
| Financing Cash Flow | $330.3M | +324.9% |
| Free Cash Flow | -$100.5M | -19.0% |
| -20.9% |
| EPS (Basic) | -$5.13 | -1.2% |
| EPS (Diluted) | -$5.13 | -1.2% |
| Stockholders' Equity |
| $205.4M |
| +198.1% |